The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?

Giovam Battista Rini, Manfredi Rizzo, Kaspar Berneis, Emanuel R. Christ, Giatgen A. Spinas

    Research output: Contribution to journalArticle

    17 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)2295-2303
    Number of pages9
    JournalExpert Opinion on Pharmacotherapy
    Volume9
    Publication statusPublished - 2008

    All Science Journal Classification (ASJC) codes

    • Pharmacology
    • Pharmacology (medical)

    Cite this

    The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance? / Rini, Giovam Battista; Rizzo, Manfredi; Berneis, Kaspar; Christ, Emanuel R.; Spinas, Giatgen A.

    In: Expert Opinion on Pharmacotherapy, Vol. 9, 2008, p. 2295-2303.

    Research output: Contribution to journalArticle

    @article{bd91b9e1cd664be8a8da31cc6eb69c97,
    title = "The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?",
    keywords = "Thiazolidindiones,Atherogenic dyslipidemia",
    author = "Rini, {Giovam Battista} and Manfredi Rizzo and Kaspar Berneis and Christ, {Emanuel R.} and Spinas, {Giatgen A.}",
    year = "2008",
    language = "English",
    volume = "9",
    pages = "2295--2303",
    journal = "Expert Opinion on Pharmacotherapy",
    issn = "1465-6566",
    publisher = "Informa Healthcare",

    }

    TY - JOUR

    T1 - The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?

    AU - Rini, Giovam Battista

    AU - Rizzo, Manfredi

    AU - Berneis, Kaspar

    AU - Christ, Emanuel R.

    AU - Spinas, Giatgen A.

    PY - 2008

    Y1 - 2008

    KW - Thiazolidindiones,Atherogenic dyslipidemia

    UR - http://hdl.handle.net/10447/36379

    M3 - Article

    VL - 9

    SP - 2295

    EP - 2303

    JO - Expert Opinion on Pharmacotherapy

    JF - Expert Opinion on Pharmacotherapy

    SN - 1465-6566

    ER -